Euroespes S.A.
Euroespes, S.A., a medical center, provides medical services for the research, diagnosis, and treatment of central nervous system disorders and other diseases in Spain and internationally. It offers personalized and genomic medicine services for predictive, diagnostic, and therapeutic purposes. The company also provides medical services, such as neuro-ophthalmology, neuro-otorhinolaryngology, neu… Read more
Market Cap & Net Worth: Euroespes S.A. (EEP)
Euroespes S.A. (MC:EEP) has a market capitalization of $4.05 Million (€3.95 Million) as of March 18, 2026. Listed on the MC stock exchange, this Spain-based company holds position #32981 globally and #128 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Euroespes S.A.'s stock price €0.34 by its total outstanding shares 11608600 (11.61 Million).
Euroespes S.A. Market Cap History: 2015 to 2026
Euroespes S.A.'s market capitalization history from 2015 to 2026. Data shows change from $10.61 Million to $4.05 Million (-5.60% CAGR).
Euroespes S.A. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Euroespes S.A.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
1.39x
Euroespes S.A.'s market cap is 1.39 times its annual revenue
0.69x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $10.61 Million | $2.86 Million | $207.23K | 3.71x | 51.18x |
| 2016 | $8.82 Million | $2.53 Million | $343.34K | 3.48x | 25.68x |
| 2017 | $10.49 Million | $2.60 Million | $105.42K | 4.04x | 99.47x |
| 2018 | $8.04 Million | $2.55 Million | -$254.25K | 3.16x | N/A |
| 2019 | $6.79 Million | $2.37 Million | -$1.26 Million | 2.86x | N/A |
| 2020 | $4.67 Million | $2.52 Million | -$411.34K | 1.85x | N/A |
| 2021 | $6.20 Million | $3.29 Million | -$183.44K | 1.88x | N/A |
| 2022 | $6.43 Million | $3.30 Million | -$1.14 Million | 1.95x | N/A |
| 2023 | $6.43 Million | $2.95 Million | -$2.13 Million | 2.18x | N/A |
| 2024 | $4.05 Million | $2.91 Million | -$323.18K | 1.39x | N/A |
Competitor Companies of EEP by Market Capitalization
Companies near Euroespes S.A. in the global market cap rankings as of March 18, 2026.
Key companies related to Euroespes S.A. by market ranking:
- Thermo Fisher Scientific Inc (NYSE:TMO): Ranked #90 globally with a market cap of $177.20 Billion USD.
- Danaher Corporation (NYSE:DHR): Ranked #151 globally with a market cap of $122.79 Billion USD.
- IDEXX Laboratories Inc (NASDAQ:IDXX): Ranked #466 globally with a market cap of $46.38 Billion USD.
- Lonza Group Ltd (PINK:LZAGF): Ranked #511 globally with a market cap of $41.73 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #90 | Thermo Fisher Scientific Inc | NYSE:TMO | $177.20 Billion | $472.71 |
| #151 | Danaher Corporation | NYSE:DHR | $122.79 Billion | $195.21 |
| #466 | IDEXX Laboratories Inc | NASDAQ:IDXX | $46.38 Billion | $586.98 |
| #511 | Lonza Group Ltd | PINK:LZAGF | $41.73 Billion | $596.13 |
Euroespes S.A. Historical Marketcap From 2015 to 2026
Between 2015 and today, Euroespes S.A.'s market cap moved from $10.61 Million to $ 4.05 Million, with a yearly change of -5.60%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €4.05 Million | 0.00% |
| 2025 | €4.05 Million | 0.00% |
| 2024 | €4.05 Million | -37.04% |
| 2023 | €6.43 Million | 0.00% |
| 2022 | €6.43 Million | +3.85% |
| 2021 | €6.20 Million | +32.65% |
| 2020 | €4.67 Million | -31.23% |
| 2019 | €6.79 Million | -15.56% |
| 2018 | €8.04 Million | -23.30% |
| 2017 | €10.49 Million | +18.92% |
| 2016 | €8.82 Million | -16.85% |
| 2015 | €10.61 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Euroespes S.A. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $4.05 Million USD |
| MoneyControl | $4.05 Million USD |
| MarketWatch | $4.05 Million USD |
| marketcap.company | $4.05 Million USD |
| Reuters | $4.05 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.